Awor previously posted saying that our problem may be very similar to post-SSRI sexual dysfunction (PSSD). I found an interesting article that I thought I would share. Finatruth is funding a study that is looking at neurosteroids in PFS patients. Maybe in the future we can join with PSSD patients as that would gain the interest of many more scientists and institutions, as well as potentially attract more funding.
Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes
pnas.org/content/96/23/13512.full.pdf
The neurosteroid 3a-hydroxysteroid-5a-pregnan-20-one (allo- pregnanolone) acts as a positive allosteric modulator of a-ami- nobutyric acid at a-aminobutyric acid type A receptors and hence is a powerful anxiolytic, anticonvulsant, and anesthetic agent. Allopregnanolone is synthesized from progesterone by reduction to 5a-dihydroprogesterone, mediated by 5a-reductase, and by reduction to allopregnanolone, mediated by 3a-hydroxysteroid dehydrogenase (3a-HSD). Previous reports suggested that some selective serotonin reuptake inhibitors (SSRIs) could alter concen- trations of allopregnanolone in human cerebral spinal fluid and in rat brain sections. We determined whether SSRIs directly altered the activities of either 5a-reductase or 3a-HSD, using an in vitro system containing purified recombinant proteins. Although rats appear to express a single 3a-HSD isoform, the human brain contains several isoforms of this enzyme, including a new isoform we cloned from human fetal brains. Our results indicate that the SSRIs fluoxetine, sertraline, and paroxetine decrease the Km of the conversion of 5a-dihydroprogesterone to allopregnanolone by human 3a-HSD type III 10- to 30-fold. Only sertraline inhibited the reverse oxidative reaction. SSRIs also affected conversions of androgens to 3a- and 3a, 17a-reduced or -oxidized androgens mediated by 3a-HSD type IIBrain. Another antidepressant, imipra- mine, was without any effect on allopregnanolone or androstan- ediol production. The region-specific expression of 3a-HSD type IIBrain and 3a-HSD type III mRNAs suggest that SSRIs will affect neurosteroid production in a region-specific manner. Our results may thus help explain the rapid alleviation of the anxiety and dysphoria associated with late luteal phase dysphoria disorder and major unipolar depression by these SSRIs.